Skip to main content
Caplight Logo









PreBiomics

PreBiomics

Private
TrentoHealthcare & Life Scienceshttps://www.prebiomics.com/

Last Round

Grant

May 1, 2023

Total Funding Raised

$3.54M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

PreBiomics is a biotechnology company that develops metagenomic techniques and AI-powered diagnostic tools to investigate the oral microbiome for personalized dental healthcare.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

metagenomicsmicrobiome analysismicrobiome testingnext-generation sequencingNGSperi-implantitisbioinformaticsprecision medicineAI diagnosticsbiotech lab servicesmetatranscriptomicsWGSwhole genome sequencingclinical diagnosticsgut health testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PreBiomics Comparables

Compare PreBiomics with similar companies based on industry and business-model similarity.

PreBiomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cmbio
77%
Access Genetics
72%
Eurofins Scientific SE
59%

PreBiomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2023
GrantOct 1, 2020
GrantMay 11, 2020
SeedOct 31, 2019

Key People

Founding team and executive leadership

Enrico Fiorini

CEO

Executive Team

Mattia Bolzan

Chief Technology Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2026

    Grew 26% QoQ, from 19 to 24 employees.

  • Aug 20, 2026

    Monthly visitors increased 68% MoM, reaching 1.1K.

PreBiomics Filings

Explore SEC and related filing metadata, where available.

PreBiomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PreBiomics's valuation, stock price, and market status.

Is PreBiomics a public or private company?

PreBiomics is a private company.

What is the current stock price of PreBiomics?

PreBiomics is a private company with no public stock price. No recent secondary market data is available.

How much is PreBiomics worth (valuation)?

Valuation information for PreBiomics is not publicly available.

Can I buy PreBiomics stock?

PreBiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PreBiomics's last funding round?

PreBiomics's most recent funding round was Grant on May 1, 2023.

Who are the main investors in PreBiomics?

Key investors in PreBiomics include Pariter Partners.

Will PreBiomics IPO soon?

No public IPO plans have been announced for PreBiomics.

How can I track PreBiomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PreBiomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTrento
Employee Range23
Year Founded2017
Last FundingMay 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?